Onderzoeker
Yana Dekempeneer
- Trefwoorden:Geneeskunde
Affiliaties
- Medische Beeldvorming (Onderzoeksgroep)
Lid
Vanaf1 okt 2015 → Heden - Ondersteunende Klinische wetenschappen (Departement)
Lid
Vanaf15 okt 2020 → Heden - Ondersteunende Klinische wetenschappen (Departement)
Lid
Vanaf1 okt 2019 → 30 jun 2020 - Ondersteunende Klinische wetenschappen (Departement)
Lid
Vanaf8 apr 2019 → 30 sep 2019 - Faculteit Economische en Sociale Wetenschappen en Solvay Business School (Faculteit)
Lid
Vanaf28 sep 2016 → 13 sep 2018 - Ondersteunende Klinische wetenschappen (Departement)
Lid
Vanaf1 okt 2015 → 20 okt 2022 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf22 sep 2015 → 2 sep 2020
Publicaties
1 - 8 van 8
- Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment(2023)
Auteurs: T Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, Janik Puttemans, Yana Dekempeneer, Kevin De Jonghe, Wout De Mey, Q Lecocq, Y De Vlaeminck, R M Awad, et al.
Pagina's: 751-758 - Preclinical evaluation of 225Ac-labeled single-domain antibody for the treatment of HER2pos cancer(2022)
Auteurs: Magdalena Rodak, Yana Dekempeneer, Maria Wojewódzka, Vicky Caveliers, Peter Covens, Brian W Miller, Matthijs B Sevenois, Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte, et al.
Pagina's: 1835-1845 - Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer.(2020)
Auteurs: Yana Dekempeneer, Vicky Caveliers, Maarten Ooms, Dominic Maertens, Mireille Gysemans, Tony Lahoutte, Catarina Xavier, Q Lecocq, Ken Maes, Peter Covens, et al.
Pagina's: 3553-3566 - Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies(2020)
Auteurs: Janik Puttemans, Yana Dekempeneer, Jos Leon Eersels, Heleen Hanssens, P Debie, M Keyaerts, K Breckpot, Q Lecocq, Tony Lahoutte, Albert D Windhorst, et al.
- Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment(2020)
Auteurs: Yana Dekempeneer, Nick Devoogdt, Vicky Caveliers, Matthias D'Huyvetter
- Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior(2019)
Auteurs: Yana Dekempeneer, Tom Back, Emma Aneheim, Holger Jensen, Janik Puttemans, Catarina Xavier, M Keyaerts, Stig Palm, Per Albertsson, Tony Lahoutte, et al.
Pagina's: 3524-3533 - Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle(2016)
Auteurs: Yana Dekempeneer, M Keyaerts, Ahmet Krasniqi, Janik Puttemans, Serge Muyldermans, Tony Lahoutte, Matthias D'Huyvetter, Nick Devoogdt
Pagina's: 1035-47 - The Therapeutic Potential of Anti-HER2 2Rs15d Nanobody Labeled with 225Ac – an In Vitro and In Vivo EvaluationEdition: 1Volume: 50
Auteurs: Marek Pruszyński, Matthias D'Huyvetter, Magdalena Rodak, Yana Dekempeneer, Tony Lahoutte, Edyta Cedrowska, Frank Bruchertseifer, Alfred Morgenstern
Pagina's: S7-S7Aantal pagina's: 1